NG-Nitroarginine Methyl Ester
"NG-Nitroarginine Methyl Ester" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.
Descriptor ID |
D019331
|
MeSH Number(s) |
D12.125.068.050.525 D12.125.095.104.525
|
Concept/Terms |
NG-Nitroarginine Methyl Ester- NG-Nitroarginine Methyl Ester
- Methyl Ester, NG-Nitroarginine
- NG Nitroarginine Methyl Ester
- N omega-Nitro-L-arginine Methyl Ester
- N omega Nitro L arginine Methyl Ester
- NG-Nitro-L-Arginine Methyl Ester
- Methyl Ester, NG-Nitro-L-Arginine
- NG Nitro L Arginine Methyl Ester
- N(G)-Nitroarginine Methyl Ester
- N(omega)-Nitro-L-arginine Methyl Ester
- L-NAME
- N(G)-Nitro-L-arginine Methyl Ester
|
Below are MeSH descriptors whose meaning is more general than "NG-Nitroarginine Methyl Ester".
Below are MeSH descriptors whose meaning is more specific than "NG-Nitroarginine Methyl Ester".
This graph shows the total number of publications written about "NG-Nitroarginine Methyl Ester" by people in this website by year, and whether "NG-Nitroarginine Methyl Ester" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 0 | 4 | 4 |
1996 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
1999 | 0 | 3 | 3 |
2000 | 0 | 2 | 2 |
2001 | 0 | 3 | 3 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2006 | 0 | 2 | 2 |
2007 | 0 | 2 | 2 |
2008 | 0 | 3 | 3 |
2009 | 1 | 1 | 2 |
2010 | 0 | 1 | 1 |
2011 | 1 | 2 | 3 |
2013 | 1 | 0 | 1 |
2015 | 0 | 1 | 1 |
2016 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "NG-Nitroarginine Methyl Ester" by people in Profiles.
-
Divergent outcomes of fructose consumption on exercise capacity of rats: friend or foe. J Appl Physiol (1985). 2017 Feb 01; 122(2):368-375.
-
BOLD quantified renal pO2 is sensitive to pharmacological challenges in rats. Magn Reson Med. 2017 07; 78(1):297-302.
-
Nitric oxide prevents alveolar senescence and emphysema in a mouse model. PLoS One. 2015; 10(3):e0116504.
-
Plasminogen activator inhibitor-1: a novel therapeutic target for hypertension? Circulation. 2013 Nov 19; 128(21):2286-8.
-
Calcium entry and a-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J Neurosci. 2013 Jun 12; 33(24):10154-64.
-
Sensitivity of USPIO-enhanced R2 imaging to dynamic blood volume changes in the rat kidney. J Magn Reson Imaging. 2011 May; 33(5):1091-9.
-
Renal oxygenation changes during water loading as evaluated by BOLD MRI: effect of NOS inhibition. J Magn Reson Imaging. 2011 Apr; 33(4):898-901.
-
Pathophysiology of chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat. Hypertens Pregnancy. 2011; 30(1):28-36.
-
Impact of endothelin A receptor antagonist selectivity in chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat. Hypertens Pregnancy. 2010; 29(3):284-93.
-
Effect of nitric oxide synthase inhibition on intrarenal oxygenation as evaluated by blood oxygenation level-dependent magnetic resonance imaging. Invest Radiol. 2009 Feb; 44(2):67-73.